-
Cyber brigandage: The need for personal insurance cover
The rise of digital transactions is fast increasing the need for cyber insurance and both insurers and the regulator must push for an awareness drive among the people.
-
Ease of doing business: Government plans to ease out over 6,000 identified compliances for the firms
India has identified 6,000 burdensome compliances, both at the central and states levels, that would be eased as part of the government’s plan to make it easier to do business towards ‘Ease of doing business in India’
-
Govt sets up expert panel to fix minimum wages
To arrive at the wage rates, the group will look into the international best practices on wages and evolve scientific criteria and methodology for the fixation of wages.
-
Delhi recorded 1,044 black fungus cases, 89 deaths till Wednesday: Health Minister Satyendar Jain
Over 92 patients have recovered till now, though there is a shortage of medicines to treat the black fungus infection.
-
WhatsApp trying to force users to accept new policy before data protection law comes: Centre to HC
The central government has urged the court to direct WhatsApp to desist from pushing notifications onto its existing users with regard to the new privacy policy.
-
Olympics chief Seiko Hashimoto says cancellation unlikely as 10,000 volunteers quit
Exactly 50 days before the opening ceremony, Tokyo 2020 president Seiko Hashimoto said the show would go on unless the pandemic stops a majority of teams from traveling.
-
Kia customers can opt for contactless car buying experience
This one-of-a-kind customised application will enable customers to connect with their nearest dealerships and get complete assistance using a video conference platform.
-
Covid-19 Vaccine: Serum Institute seeks test licence from DCGI to manufacture Sputnik V
The Serum Institute of India (SII) has put up an application to the Drugs Controller General of India seeking permission for a test licence to manufacture Sputnik V.
-
Covid Vaccination: Centre finalises advance agreement with Biological E for 30 crore doses
The Covid-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials
-
Uday Kotak applauds the American model of printing more money
On 28 May, Kotak had asked both the Reserve Bank of India (RBI) and the government of India to print more money to help India overcome the covid-induced impact on the economy.
